Literaturnachweis - Detailanzeige
Autor/inn/en | Armstrong, Robert B.; Damaraju, C. V.; Ascher, Steve; Schwarzman, Lesley; O'Neill, James; Starr, H. Lynn |
---|---|
Titel | Time Course of Treatment Effect of OROS[R] Methylphenidate in Children with ADHD |
Quelle | In: Journal of Attention Disorders, 16 (2012) 8, S. 697-705
PDF als Volltext |
Sprache | englisch |
Dokumenttyp | gedruckt; online; Zeitschriftenaufsatz |
ISSN | 1087-0547 |
DOI | 10.1177/1087054711425772 |
Schlagwörter | Forschungsbericht; Mathematics Tests; Laboratory Schools; Attention Deficit Hyperactivity Disorder; Drug Therapy; Children; Scores; Measures (Individuals); Statistical Analysis; Participant Characteristics |
Abstract | Objective: The authors evaluated the time course of the treatment effect of Osmotic-Release Oral System methylphenidate (OROS[R] MPH) HCl (Concerta[R], Raritan, NJ) CII in children with ADHD. Method: Data were combined from two double-blind, randomized, placebo-controlled, cross-over, analog classroom studies in children (9-12 years) with ADHD. Participants received an individualized dose of placebo or OROS[R] MPH on two laboratory school days. Permanent Product Math Test and Swanson, Kotkin, Agler, M-Flynn, and Pelham scores were evaluated 0.5 hr before dosing and 1, 2, 4, 10, 11, and 12.5 hr post dose. Analysis used a repeated-measures mixed model. Results: Treatment effects were present at all postdose assessment points (p less than 0.0001 for all comparisons, n = 139). Adverse events were similar to previous reports for OROS[R] MPH. Conclusion: A robust treatment effect occurred with OROS[R] MPH; onset was at 1 hr and persisted for at least 12.5 hr after dosing. (Contains 2 tables and 3 figures.) (As Provided). |
Anmerkungen | SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: http://sagepub.com |
Begutachtung | Peer reviewed |
Erfasst von | ERIC (Education Resources Information Center), Washington, DC |
Update | 2017/4/10 |